Dr. Charles M. Rudin discussed recent treatment advancements for patients with small cell lung cancer. During the CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York ...
AstraZeneca, in collaboration with the Vietnam Cancer Association, organized a scientific symposium titled "A new era in lung ...
Lung Cancer Awareness Month highlights the importance of staying informed about advancements, screening, and preventive measures in lung cancer care. Significant advancements include early detection ...
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
MSK experts discuss FLAURA2 updates, emerging targets in mesothelioma, and next-gen immunotherapies from the 2026 European ...
This press release is not intended for US or UK media. Ingelheim, Germany and Ridgefield, Conn.Boehringer Ingelheim today announced that The New ...
What Is Hyrnuo, and Why Does It Matter? Hyrnuo (sevabertinib) is a new oral medicine for adults with advanced nonsquamous non-small-cell lung cancer (NSCLC) carrying a specific genetic change known as ...
Key Takeaways Catching tumors early is crucial to lung cancer survivalNew robotic technologies, along with other innovations, ...
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in ...
NAPT recognized Dr. Frank at the 2026 NPC with its Accelerator Award for Clinical Achievement, honoring exceptional clinicians who demonstrate leadership in proton therapy and play a pivotal role in ...
The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results